Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis od Robson, J, Dawson, J, Cronholm, P, Ashdown, S, Easley, E, Kellom, K, Gebhart, D, Lanier, G, Milman, N, Peck, J, Luqmani, R, Shea, J, Tomasson, G, Merkel, P

Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire od Robson, J, Dawson, J, Doll, H, Cronholm, P, Milman, N, Kellom, K, Ashdown, S, Easley, E, Gebhart, D, Lanier, G, Mills, J, Peck, J, Luqmani, R, Shea, J, Tomasson, G, Merkel, P

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure od Robson JC, Dawson J, Cronholm PF, Milman N, Kellom KS, Ashdown S, Easley E, Farrar JT, Gebhart D, Lanier G, McAlear CA, Peck J, Luqmani RA, Shea JA, Tomasson G, Merkel PA

Dokumenty pełnotekstowe

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure od Robson, J, Dawson, J, Cronholm, P, Milman, N, Kellom, K, Ashdown, S, Easley, E, Farrar, J, Gebhart, D, Lanier, G, McAlear, C, Peck, J, Luqmani, R, Shea, J, Tomasson, G, Merkel, P

Scale Structure and Measurement Properties of a Disease Specific Patient-Reported Outcome for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis od Robson, J, Dawson, J, Shea, J, Doll, H, Ashdown, S, Borchin, R, Easley, E, Farrar, J, Gebhart, D, Kellom, K, Lanier, G, Luqmani, R, McAlear, C, Mills, J, Milman, N, Peck, J, Tomasson, G, Cronholm, P

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytopl... od Robson, J, Dawson, J, Shea, J, Doll, H, Ashdown, S, Borchin, R, Easley, E, Farrar, J, Gebhart, D, Kellom, K, Lanier, G, Luqmani, R, McAlear, C, Mills, J, Milman, N, Peck, J, Tomasson, G, Cronholm, P, Merkel, P

A disease-specific patient-reported outcome for ANCA associated vasculitis: scale structure and measurement properties of the AAV- PRO od Robson, J, Dawson, J, Shea, J, Doll, H, Ashdown, S, Borchin, R, Easley, E, Farrar, J, Gebhart, D, Kellom, K, Lanier, G, Luqmani, R, McAlear, C, Mills, J, Milman, N, Peck, J, Tomasson, G, Cronholm, P, Merkel, P

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis od Robson, J, Tomasson, G, Milman, N, Ashdown, S, Boonen, A, Casey, G, Cronholm, P, Cuthbertson, D, Dawson, J, Direskeneli, H, Easley, E, Kermani, T, Farrar, J, Gebhart, D, Lanier, G, Luqmani, R, Mahr, A, McAlear, C, Peck, J, Shea, B, Shea, J, Sreih, A, Tugwell, P, Merkel, P

Feasibility and construct validation of the patient reported outcomes measurement information system in systemic vasculitis od Tomasson, G, Farrar, JT, Cuthbertson, D, McAlear, CA, Ashdown, S, Cronholm, PF, Dawson, J, Gebhart, D, Lanier, G, Luqmani, RA, Milman, N, Peck, J, Robson, JC, Shea, JA, Carette, S, Khalidi, N, Koening, CL, Langford, CA, Monach, PA, Moreland, L, Pagnoux, C, Specks, U, Sreih, AG, Ytterberg, SR, Merkel, PA, Vasculitis Clinical Research Consortium